 The Prescription Drug User Fee Amendments of 2002 amends the Federal Food, Drug, and Cosmetic Act to revise provisions concerning definitions and the authority to assess and use drug fees.It provides public accountability for goals in the process for the review of human drug applications.It revises provisions concerning reports of postmarketing studies.